In 2018, Denmark began a trial period which meant that doctors are allowed to prescribe medical cannabis. The aim was that pain patients, who have tried other medications without improvement, could have access to cannabis.
The trial period ran until the end of 2025, but already now a broad majority in the Norwegian Parliament has entered into an agreement to make the law permanent.
The new law will target patients with multiple sclerosis, spinal cord injuries, cancer or chronic pain.
“Many experience less pain or nausea, which can significantly improve the quality of life,” says Minister of Social Affairs Sophie Løhde (V) in a press release.
“With the agreement, we ensure that patients, who have not experienced a satisfactory effect from other medications, will also be able to get medical cannabis prescribed under safe conditions in the future”.
Several doctors in Denmark have criticized the temporary law and hesitated to prescribe cannabis. Above all, they have directed criticism at the fact that patients do not receive enough information about effects and side effects.